Navigating biosimilar approvals: start conversations early, says IP lawyer
The biosimilar market is rapidly growing after experiencing several significant developments in 2015 and is expected to be worth more than $32 billion by 2025.
Archives for January 5, 2016
Biologic makers looking to delivery devices to gain competitive edge, Bespak
Having a proactive approach to delivery technologies will give pharma firms a competitive edge against biosimilars and biobetters, according to device maker Bespak.
Single-use perfusion tech will cut cost of vaccine production, says Univercells
Univercells has received a grant of over $500,000 to help develop a single-use platform to reduce the cost of manufacturing antibodies and vaccines.